Login

Kuvera interviews Rahul Singh, Chief Investment Officer - Equities at Tata Asset Management, about Multi Cap Funds.|Gaurav Rastogi is the CEO of Kuvera 00:10:00

Share On Facebook Share On Twitter

Gaurav Rastogi is the CEO of Kuvera

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Doron Blachar Discusses Pandemic's Impact on Ormat Technologies' Operations | Doron Blachar, CEO , Ormat Technologies, Inc.
00:10:00
Spotlight Series: Unveiling the Brilliance of Feyza Ciritoglu at Mobimo AG
00:10:00
Inside DUG: Colin La Galia on Cybersecurity and Navigating Data Breaches | Colin La Galia, CCO , Dug Technology Ltd.
00:10:00
FinovateEurope 2017 | Oliver Weber, CEO, Crealogix Holding AGCLXN:SWX
00:10:00
Tom Kozlik of HilltopSecurities discusses muni bonds and the effects of banking sector anxiety with CNBC's Kelly Evans on "The Exchange."
00:10:00
April Sees Gains in ADS, Occupancy, and RN Care Minutes Across Aged Care Sector
00:10:00
Norse Inc: Advancing High-Grade Critical Minerals Project in NWT
00:10:00
Bonds, Technology, and Global Markets: An In-Depth Discussion with PGIM CEO David Hunt | David Hunt, CEO , PGIM.
00:10:00
Helium1 CEO David Minchin Highlights World's Largest Helium Resource Discovery
00:10:00
Wahid Nawabi, AeroVironment CEO, addresses production capacity, government contracts, earnings, and other pertinent topics on 'Closing Bell Overtime'.
00:10:00
actively partner with founders from a wide range of companies|Abheek Anand,Managing Director,Sequoia Capital India
00:10:00
Sun Products' Strategic Growth and Market Transformation

© 2026 Nehu